AI
CRDF icon

Atom Investors’s Cardiff Oncology CRDF Stock Holding History

Atom Investors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-71,051
Closed -$224K – 642
2025
Q2 		$224K Buy
+71,051
New +$217K 0.02% 492
2024
Q2 		– Sell
-15,298
Closed -$81.7K – 518
2024
Q1 		$81.7K Sell
15,298
-2,722
-15% -$7.23K 0.01% 532
2023
Q4 		$26.7K Sell
18,020
-278
-2% -$336 ﹤0.01% 436
2023
Q3 		$25.4K Hold
18,298
– – 0.01% 418
2023
Q2 		$26.9K Hold
18,298
– – 0.01% 276
2023
Q1 		$30.2K Hold
18,298
– – 0.02% 240
2022
Q4 		$25.6K Hold
18,298
– – 0.01% 211
2022
Q3 		$28K Sell
18,298
-15,500
-46% -$37.3K 0.01% 265
2022
Q2 		$74K Hold
33,798
– – 0.03% 226
2022
Q1 		$84K Buy
+33,798
New +$120K 0.04% 178

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Atom Investors's CRDF Position: Q3 2025 in Review

Atom Investors sold out of Cardiff Oncology (CRDF) in Q3 2025, closing a stake of 71,051 shares — an estimated $224K sold.

Atom Investors first reported a position in CRDF in Q1 2022 and held it in 10 quarters. The position peaked at $224K in Q2 2025. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.

  • Atom Investors reported no remaining Cardiff Oncology position as of Q3 2025 after selling out during the quarter.
  • Atom Investors sold 71,051 Cardiff Oncology shares in Q3 2025, an estimated $224K.
  • Atom Investors first reported a position in Cardiff Oncology in Q1 2022 and held it in 10 quarters.
  • Atom Investors's Cardiff Oncology position peaked at $224K in Q2 2025.
  • 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.